• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节肾素-血管紧张素系统及醛固酮分泌的多巴胺能受体机制:综述

Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.

作者信息

Missale C, Lombardi C, De Cotiis R, Memo M, Carruba M O, Spano P F

机构信息

Institute of Pharmacology and Experimental Therapeutics, School of Medicine, University of Brescia, Italy.

出版信息

J Cardiovasc Pharmacol. 1989;14 Suppl 8:S29-39.

PMID:2483440
Abstract

Several studies suggested that dopamine may be one of the inhibitory modulators of aldosterone secretion. Metoclopramide, a selective antagonist for dopamine D-2 receptors, increases both basal plasma aldosterone levels and the aldosterone response to angiotensin II (Ang II) in rats and humans kept on a high sodium intake, these effects being blocked by dopamine infusion. Dopamine, which has no significant effects on Ang II-induced aldosterone secretion in sodium-replete subjects, inhibits the hormonal response to Ang II infusion in sodium-depleted normal subjects, suggesting that the sodium balance state may be an important factor in the dopaminergic mechanisms controlling aldosterone secretion. The effect of dopamine on the hormone production is mediated by D-2 receptors in the adrenal cortex as shown by in vitro studies with isolated adrenal glomerulosa cells. Clinical studies have shown that dihydroergotoxine, a selective D-2 agonist, suppresses the aldosterone secretion induced by sodium depletion in hypertensive patients, an effect blocked by sulpiride. This mechanism could be of relevant therapeutic interest in its contribution to the natriuretic effects of dopaminergic agonists, which have clinical applications in the treatment of hypertension and congestive heart failure.

摘要

多项研究表明,多巴胺可能是醛固酮分泌的抑制性调节因子之一。甲氧氯普胺是一种多巴胺D - 2受体的选择性拮抗剂,在高钠摄入的大鼠和人类中,它会增加基础血浆醛固酮水平以及醛固酮对血管紧张素II(Ang II)的反应,多巴胺输注可阻断这些作用。多巴胺在钠充足的受试者中对Ang II诱导的醛固酮分泌无显著影响,但在钠缺乏的正常受试者中会抑制对Ang II输注的激素反应,这表明钠平衡状态可能是多巴胺能机制控制醛固酮分泌的一个重要因素。体外对分离的肾上腺球状带细胞的研究表明,多巴胺对激素产生的作用是由肾上腺皮质中的D - 2受体介导的。临床研究表明,选择性D - 2激动剂双氢麦角毒碱可抑制高血压患者因钠缺乏诱导的醛固酮分泌,舒必利可阻断这一作用。这种机制可能与其对多巴胺能激动剂利钠作用的贡献具有相关治疗意义,多巴胺能激动剂在高血压和充血性心力衰竭的治疗中具有临床应用价值。

相似文献

1
Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.调节肾素-血管紧张素系统及醛固酮分泌的多巴胺能受体机制:综述
J Cardiovasc Pharmacol. 1989;14 Suppl 8:S29-39.
2
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure.
J Cardiovasc Pharmacol. 1989;14 Suppl 8:S72-6.
3
Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.心房利钠因子对血压及肾素-血管紧张素-醛固酮系统的影响。
Fed Proc. 1986 Jun;45(7):2115-21.
4
Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors.
J Pharmacol Exp Ther. 1988 Sep;246(3):1137-43.
5
[Recent progress in dopaminergic control of aldosterone secretion].[多巴胺能对醛固酮分泌的调控研究进展]
Minerva Med. 1989 Mar;80(3):241-8.
6
Dopaminergic modulation of aldosterone secretion in the rat.大鼠中多巴胺能对醛固酮分泌的调节
Endocrinology. 1984 Jan;114(1):176-81. doi: 10.1210/endo-114-1-176.
7
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.甲氧氯普胺诱导的人体醛固酮分泌的多巴胺能抑制作用。对多巴胺和溴隐亭反应的解离。
J Clin Invest. 1980 Jul;66(1):10-8. doi: 10.1172/JCI109822.
8
Dopamine selectively inhibits aldosterone responses to angiotensin II in man.多巴胺可选择性抑制人类醛固酮对血管紧张素II的反应。
J Hypertens Suppl. 1984 Dec;2(3):S267-9.
9
Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells.多巴胺抑制牛肾上腺细胞中血管紧张素刺激的醛固酮生物合成。
J Clin Invest. 1979 Jul;64(1):287-91. doi: 10.1172/JCI109450.
10
The role of dopamine in nonmodulating hypertension.
J Clin Endocrinol Metab. 1989 Aug;69(2):426-32. doi: 10.1210/jcem-69-2-426.

引用本文的文献

1
The dopaminergic control of Cushing's syndrome.多巴胺对库欣综合征的控制。
J Endocrinol Invest. 2022 Jul;45(7):1297-1315. doi: 10.1007/s40618-021-01661-x. Epub 2022 Apr 23.
2
Methamphetamine and dopamine receptor D1 regulate entrainment of murine circadian oscillators.甲基苯丙胺和多巴胺受体 D1 调节小鼠生物钟振荡器的同步。
PLoS One. 2013 Apr 23;8(4):e62463. doi: 10.1371/journal.pone.0062463. Print 2013.
3
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome.生长抑素和多巴胺受体作为库欣综合征医学治疗的靶点。
Rev Endocr Metab Disord. 2009 Jun;10(2):91-102. doi: 10.1007/s11154-008-9082-4. Epub 2008 Jul 19.
4
Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure.高肾素性低醛固酮血症:脓毒症休克诱导的急性肾衰竭的一个可能病因。
Intensive Care Med. 2003 Oct;29(10):1703-9. doi: 10.1007/s00134-003-1986-6. Epub 2003 Aug 28.
5
Role of the renin-angiotensin system in the compensation of quinpirole-induced blood pressure decrease.肾素-血管紧张素系统在喹吡罗诱导的血压降低代偿中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2003 May;367(5):427-33. doi: 10.1007/s00210-003-0740-5. Epub 2003 Apr 23.
6
Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule.多巴胺可降低肾近端小管中1型血管紧张素II受体的表达。
J Clin Invest. 1996 Jun 15;97(12):2745-52. doi: 10.1172/JCI118729.